Skip to Main Content

Paper Details

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors.
Oncologist
12
2016
NET, NETs, Neuroendocrine Tumors, Octreotide, PATIENTS, Patients, carcinoid syndromes, neuroendocrine, neuroendocrine tumors, octreotide, octreotide LAR, patients
Author NameAffiliation
Chan ShenDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center
Ying XuDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2